SEC Form 4 · accession 0001225208-17-007199
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Young
Officer — Group President
Period of report
Mar 31, 2017
Accepted (ET)
Apr 3, 2017 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2017 | G | 8,732 | $0.00 | D | 127,992 | D | |
| Common Stock | holding | — | — | — | 1,513 | I | By Rule 16b-3 Plan | |
| Common Stock | holding | — | — | — | 1,385 | I | By Trustee under the Pfizer Share Ownership Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock Units SSPF1,F2 | — | Mar 31, 2017 | A | 11 | A | — | — | Common Stock | 11 | 8,206 | D |
Explanation of responses
- F1Each unit represents one phantom share of common stock.
- F2These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.